Not because the medicine is unknown — but because the current evidence, the right second opinion, and the matching clinical trial don’t always reach the room in time. Guidelines change every few weeks; most tumour boards catch up every few months. Radiologists read more mammograms than ever. The knowledge that should compound, instead disappears at the end of each case.

Spain’s regions have already decided this is worth solving. Madrid announced in 2026 it is deploying AI to help read breast and prostate cancer imaging. Andalucía has put €316.5M behind digital health and AI through 2030, cancer screening included. What’s missing is a partner who brings something already proven and safe to start with, and a way to grow it a public system can trust.

That’s why we’re here.